Global Arthritis Drug Market Growth 2025-2031

October 2025 | 92 pages | ID: G7C5DF60D00AEN
LP Information

Abstracts

The global Arthritis Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, are among others.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the ?Arthritis Drug Industry Forecast? looks at past sales and reviews total world Arthritis Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Arthritis Drug sales for 2025 through 2031. With Arthritis Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Arthritis Drug industry.

This Insight Report provides a comprehensive analysis of the global Arthritis Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Arthritis Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Arthritis Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Arthritis Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Arthritis Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Arthritis Drug market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Synthetic DMARDs
• Biological DMARDs
• NSAIDs
• Corticosteroids
• Analgesics

Segmentation by Application:

• Retail Pharmacies
• Hospital Pharmacies
• Drug Stores
• E-Commerce

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Novartis
• Eli Lilly
• Celltrion
• F. Hoffmann-La Roche
• Pfizer
• Johnson & Johnson
• GSK

Key Questions Addressed in this Report

What is the 10-year outlook for the global Arthritis Drug market?
What factors are driving Arthritis Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Arthritis Drug market opportunities vary by end market size?
How does Arthritis Drug break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Arthritis Drug Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Arthritis Drug by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Arthritis Drug by Country/Region, 2020, 2024 & 2031
2.2 Arthritis Drug Segment by Type
  2.2.1 Synthetic DMARDs
  2.2.2 Biological DMARDs
  2.2.3 NSAIDs
  2.2.4 Corticosteroids
  2.2.5 Analgesics
2.3 Arthritis Drug Sales by Type
  2.3.1 Global Arthritis Drug Sales Market Share by Type (2020-2025)
  2.3.2 Global Arthritis Drug Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Arthritis Drug Sale Price by Type (2020-2025)
2.4 Arthritis Drug Segment by Application
  2.4.1 Retail Pharmacies
  2.4.2 Hospital Pharmacies
  2.4.3 Drug Stores
  2.4.4 E-Commerce
2.5 Arthritis Drug Sales by Application
  2.5.1 Global Arthritis Drug Sale Market Share by Application (2020-2025)
  2.5.2 Global Arthritis Drug Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Arthritis Drug Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Arthritis Drug Breakdown Data by Company
  3.1.1 Global Arthritis Drug Annual Sales by Company (2020-2025)
  3.1.2 Global Arthritis Drug Sales Market Share by Company (2020-2025)
3.2 Global Arthritis Drug Annual Revenue by Company (2020-2025)
  3.2.1 Global Arthritis Drug Revenue by Company (2020-2025)
  3.2.2 Global Arthritis Drug Revenue Market Share by Company (2020-2025)
3.3 Global Arthritis Drug Sale Price by Company
3.4 Key Manufacturers Arthritis Drug Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Arthritis Drug Product Location Distribution
  3.4.2 Players Arthritis Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ARTHRITIS DRUG BY GEOGRAPHIC REGION

4.1 World Historic Arthritis Drug Market Size by Geographic Region (2020-2025)
  4.1.1 Global Arthritis Drug Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Arthritis Drug Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Arthritis Drug Market Size by Country/Region (2020-2025)
  4.2.1 Global Arthritis Drug Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Arthritis Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Arthritis Drug Sales Growth
4.4 APAC Arthritis Drug Sales Growth
4.5 Europe Arthritis Drug Sales Growth
4.6 Middle East & Africa Arthritis Drug Sales Growth

5 AMERICAS

5.1 Americas Arthritis Drug Sales by Country
  5.1.1 Americas Arthritis Drug Sales by Country (2020-2025)
  5.1.2 Americas Arthritis Drug Revenue by Country (2020-2025)
5.2 Americas Arthritis Drug Sales by Type (2020-2025)
5.3 Americas Arthritis Drug Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Arthritis Drug Sales by Region
  6.1.1 APAC Arthritis Drug Sales by Region (2020-2025)
  6.1.2 APAC Arthritis Drug Revenue by Region (2020-2025)
6.2 APAC Arthritis Drug Sales by Type (2020-2025)
6.3 APAC Arthritis Drug Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Arthritis Drug by Country
  7.1.1 Europe Arthritis Drug Sales by Country (2020-2025)
  7.1.2 Europe Arthritis Drug Revenue by Country (2020-2025)
7.2 Europe Arthritis Drug Sales by Type (2020-2025)
7.3 Europe Arthritis Drug Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Arthritis Drug by Country
  8.1.1 Middle East & Africa Arthritis Drug Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Arthritis Drug Revenue by Country (2020-2025)
8.2 Middle East & Africa Arthritis Drug Sales by Type (2020-2025)
8.3 Middle East & Africa Arthritis Drug Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Arthritis Drug
10.3 Manufacturing Process Analysis of Arthritis Drug
10.4 Industry Chain Structure of Arthritis Drug

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Arthritis Drug Distributors
11.3 Arthritis Drug Customer

12 WORLD FORECAST REVIEW FOR ARTHRITIS DRUG BY GEOGRAPHIC REGION

12.1 Global Arthritis Drug Market Size Forecast by Region
  12.1.1 Global Arthritis Drug Forecast by Region (2026-2031)
  12.1.2 Global Arthritis Drug Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Arthritis Drug Forecast by Type (2026-2031)
12.7 Global Arthritis Drug Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Novartis
  13.1.1 Novartis Company Information
  13.1.2 Novartis Arthritis Drug Product Portfolios and Specifications
  13.1.3 Novartis Arthritis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Novartis Main Business Overview
  13.1.5 Novartis Latest Developments
13.2 Eli Lilly
  13.2.1 Eli Lilly Company Information
  13.2.2 Eli Lilly Arthritis Drug Product Portfolios and Specifications
  13.2.3 Eli Lilly Arthritis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Eli Lilly Main Business Overview
  13.2.5 Eli Lilly Latest Developments
13.3 Celltrion
  13.3.1 Celltrion Company Information
  13.3.2 Celltrion Arthritis Drug Product Portfolios and Specifications
  13.3.3 Celltrion Arthritis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Celltrion Main Business Overview
  13.3.5 Celltrion Latest Developments
13.4 F. Hoffmann-La Roche
  13.4.1 F. Hoffmann-La Roche Company Information
  13.4.2 F. Hoffmann-La Roche Arthritis Drug Product Portfolios and Specifications
  13.4.3 F. Hoffmann-La Roche Arthritis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 F. Hoffmann-La Roche Main Business Overview
  13.4.5 F. Hoffmann-La Roche Latest Developments
13.5 Pfizer
  13.5.1 Pfizer Company Information
  13.5.2 Pfizer Arthritis Drug Product Portfolios and Specifications
  13.5.3 Pfizer Arthritis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Pfizer Main Business Overview
  13.5.5 Pfizer Latest Developments
13.6 Johnson & Johnson
  13.6.1 Johnson & Johnson Company Information
  13.6.2 Johnson & Johnson Arthritis Drug Product Portfolios and Specifications
  13.6.3 Johnson & Johnson Arthritis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Johnson & Johnson Main Business Overview
  13.6.5 Johnson & Johnson Latest Developments
13.7 GSK
  13.7.1 GSK Company Information
  13.7.2 GSK Arthritis Drug Product Portfolios and Specifications
  13.7.3 GSK Arthritis Drug Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 GSK Main Business Overview
  13.7.5 GSK Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Arthritis Drug Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Arthritis Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Synthetic DMARDs
Table 4. Major Players of Biological DMARDs
Table 5. Major Players of NSAIDs
Table 6. Major Players of Corticosteroids
Table 7. Major Players of Analgesics
Table 8. Global Arthritis Drug Sales by Type (2020-2025) & (K Units)
Table 9. Global Arthritis Drug Sales Market Share by Type (2020-2025)
Table 10. Global Arthritis Drug Revenue by Type (2020-2025) & ($ million)
Table 11. Global Arthritis Drug Revenue Market Share by Type (2020-2025)
Table 12. Global Arthritis Drug Sale Price by Type (2020-2025) & (USD/Unit)
Table 13. Global Arthritis Drug Sale by Application (2020-2025) & (K Units)
Table 14. Global Arthritis Drug Sale Market Share by Application (2020-2025)
Table 15. Global Arthritis Drug Revenue by Application (2020-2025) & ($ million)
Table 16. Global Arthritis Drug Revenue Market Share by Application (2020-2025)
Table 17. Global Arthritis Drug Sale Price by Application (2020-2025) & (USD/Unit)
Table 18. Global Arthritis Drug Sales by Company (2020-2025) & (K Units)
Table 19. Global Arthritis Drug Sales Market Share by Company (2020-2025)
Table 20. Global Arthritis Drug Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Arthritis Drug Revenue Market Share by Company (2020-2025)
Table 22. Global Arthritis Drug Sale Price by Company (2020-2025) & (USD/Unit)
Table 23. Key Manufacturers Arthritis Drug Producing Area Distribution and Sales Area
Table 24. Players Arthritis Drug Products Offered
Table 25. Arthritis Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Arthritis Drug Sales by Geographic Region (2020-2025) & (K Units)
Table 29. Global Arthritis Drug Sales Market Share Geographic Region (2020-2025)
Table 30. Global Arthritis Drug Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Arthritis Drug Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Arthritis Drug Sales by Country/Region (2020-2025) & (K Units)
Table 33. Global Arthritis Drug Sales Market Share by Country/Region (2020-2025)
Table 34. Global Arthritis Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Arthritis Drug Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Arthritis Drug Sales by Country (2020-2025) & (K Units)
Table 37. Americas Arthritis Drug Sales Market Share by Country (2020-2025)
Table 38. Americas Arthritis Drug Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Arthritis Drug Sales by Type (2020-2025) & (K Units)
Table 40. Americas Arthritis Drug Sales by Application (2020-2025) & (K Units)
Table 41. APAC Arthritis Drug Sales by Region (2020-2025) & (K Units)
Table 42. APAC Arthritis Drug Sales Market Share by Region (2020-2025)
Table 43. APAC Arthritis Drug Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Arthritis Drug Sales by Type (2020-2025) & (K Units)
Table 45. APAC Arthritis Drug Sales by Application (2020-2025) & (K Units)
Table 46. Europe Arthritis Drug Sales by Country (2020-2025) & (K Units)
Table 47. Europe Arthritis Drug Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Arthritis Drug Sales by Type (2020-2025) & (K Units)
Table 49. Europe Arthritis Drug Sales by Application (2020-2025) & (K Units)
Table 50. Middle East & Africa Arthritis Drug Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & Africa Arthritis Drug Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Arthritis Drug Sales by Type (2020-2025) & (K Units)
Table 53. Middle East & Africa Arthritis Drug Sales by Application (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Arthritis Drug
Table 55. Key Market Challenges & Risks of Arthritis Drug
Table 56. Key Industry Trends of Arthritis Drug
Table 57. Arthritis Drug Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Arthritis Drug Distributors List
Table 60. Arthritis Drug Customer List
Table 61. Global Arthritis Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 62. Global Arthritis Drug Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Arthritis Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 64. Americas Arthritis Drug Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Arthritis Drug Sales Forecast by Region (2026-2031) & (K Units)
Table 66. APAC Arthritis Drug Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Arthritis Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Europe Arthritis Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Arthritis Drug Sales Forecast by Country (2026-2031) & (K Units)
Table 70. Middle East & Africa Arthritis Drug Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Arthritis Drug Sales Forecast by Type (2026-2031) & (K Units)
Table 72. Global Arthritis Drug Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Arthritis Drug Sales Forecast by Application (2026-2031) & (K Units)
Table 74. Global Arthritis Drug Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Novartis Basic Information, Arthritis Drug Manufacturing Base, Sales Area and Its Competitors
Table 76. Novartis Arthritis Drug Product Portfolios and Specifications
Table 77. Novartis Arthritis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Novartis Main Business
Table 79. Novartis Latest Developments
Table 80. Eli Lilly Basic Information, Arthritis Drug Manufacturing Base, Sales Area and Its Competitors
Table 81. Eli Lilly Arthritis Drug Product Portfolios and Specifications
Table 82. Eli Lilly Arthritis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Eli Lilly Main Business
Table 84. Eli Lilly Latest Developments
Table 85. Celltrion Basic Information, Arthritis Drug Manufacturing Base, Sales Area and Its Competitors
Table 86. Celltrion Arthritis Drug Product Portfolios and Specifications
Table 87. Celltrion Arthritis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Celltrion Main Business
Table 89. Celltrion Latest Developments
Table 90. F. Hoffmann-La Roche Basic Information, Arthritis Drug Manufacturing Base, Sales Area and Its Competitors
Table 91. F. Hoffmann-La Roche Arthritis Drug Product Portfolios and Specifications
Table 92. F. Hoffmann-La Roche Arthritis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. F. Hoffmann-La Roche Main Business
Table 94. F. Hoffmann-La Roche Latest Developments
Table 95. Pfizer Basic Information, Arthritis Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Arthritis Drug Product Portfolios and Specifications
Table 97. Pfizer Arthritis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. Johnson & Johnson Basic Information, Arthritis Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Johnson & Johnson Arthritis Drug Product Portfolios and Specifications
Table 102. Johnson & Johnson Arthritis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Johnson & Johnson Main Business
Table 104. Johnson & Johnson Latest Developments
Table 105. GSK Basic Information, Arthritis Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. GSK Arthritis Drug Product Portfolios and Specifications
Table 107. GSK Arthritis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. GSK Main Business
Table 109. GSK Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Arthritis Drug
Figure 2. Arthritis Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Arthritis Drug Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Arthritis Drug Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Arthritis Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Arthritis Drug Sales Market Share by Country/Region (2024)
Figure 10. Arthritis Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Synthetic DMARDs
Figure 12. Product Picture of Biological DMARDs
Figure 13. Product Picture of NSAIDs
Figure 14. Product Picture of Corticosteroids
Figure 15. Product Picture of Analgesics
Figure 16. Global Arthritis Drug Sales Market Share by Type in 2025
Figure 17. Global Arthritis Drug Revenue Market Share by Type (2020-2025)
Figure 18. Arthritis Drug Consumed in Retail Pharmacies
Figure 19. Global Arthritis Drug Market: Retail Pharmacies (2020-2025) & (K Units)
Figure 20. Arthritis Drug Consumed in Hospital Pharmacies
Figure 21. Global Arthritis Drug Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 22. Arthritis Drug Consumed in Drug Stores
Figure 23. Global Arthritis Drug Market: Drug Stores (2020-2025) & (K Units)
Figure 24. Arthritis Drug Consumed in E-Commerce
Figure 25. Global Arthritis Drug Market: E-Commerce (2020-2025) & (K Units)
Figure 26. Global Arthritis Drug Sale Market Share by Application (2024)
Figure 27. Global Arthritis Drug Revenue Market Share by Application in 2025
Figure 28. Arthritis Drug Sales by Company in 2025 (K Units)
Figure 29. Global Arthritis Drug Sales Market Share by Company in 2025
Figure 30. Arthritis Drug Revenue by Company in 2025 ($ millions)
Figure 31. Global Arthritis Drug Revenue Market Share by Company in 2025
Figure 32. Global Arthritis Drug Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Arthritis Drug Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Arthritis Drug Sales 2020-2025 (K Units)
Figure 35. Americas Arthritis Drug Revenue 2020-2025 ($ millions)
Figure 36. APAC Arthritis Drug Sales 2020-2025 (K Units)
Figure 37. APAC Arthritis Drug Revenue 2020-2025 ($ millions)
Figure 38. Europe Arthritis Drug Sales 2020-2025 (K Units)
Figure 39. Europe Arthritis Drug Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Arthritis Drug Sales 2020-2025 (K Units)
Figure 41. Middle East & Africa Arthritis Drug Revenue 2020-2025 ($ millions)
Figure 42. Americas Arthritis Drug Sales Market Share by Country in 2025
Figure 43. Americas Arthritis Drug Revenue Market Share by Country (2020-2025)
Figure 44. Americas Arthritis Drug Sales Market Share by Type (2020-2025)
Figure 45. Americas Arthritis Drug Sales Market Share by Application (2020-2025)
Figure 46. United States Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Arthritis Drug Sales Market Share by Region in 2025
Figure 51. APAC Arthritis Drug Revenue Market Share by Region (2020-2025)
Figure 52. APAC Arthritis Drug Sales Market Share by Type (2020-2025)
Figure 53. APAC Arthritis Drug Sales Market Share by Application (2020-2025)
Figure 54. China Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 58. India Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Arthritis Drug Sales Market Share by Country in 2025
Figure 62. Europe Arthritis Drug Revenue Market Share by Country (2020-2025)
Figure 63. Europe Arthritis Drug Sales Market Share by Type (2020-2025)
Figure 64. Europe Arthritis Drug Sales Market Share by Application (2020-2025)
Figure 65. Germany Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 66. France Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Arthritis Drug Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Arthritis Drug Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa Arthritis Drug Sales Market Share by Application (2020-2025)
Figure 73. Egypt Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Arthritis Drug Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Arthritis Drug in 2025
Figure 79. Manufacturing Process Analysis of Arthritis Drug
Figure 80. Industry Chain Structure of Arthritis Drug
Figure 81. Channels of Distribution
Figure 82. Global Arthritis Drug Sales Market Forecast by Region (2026-2031)
Figure 83. Global Arthritis Drug Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global Arthritis Drug Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global Arthritis Drug Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global Arthritis Drug Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global Arthritis Drug Revenue Market Share Forecast by Application (2026-2031)